Evidence map›Paper›PMID 29243164›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2018

Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.

Ian R Kleckner, Charles Kamen, Jennifer S Gewandter, Nimish A Mohile, Charles E Heckler, Eva Culakova, Chunkit Fung, Michelle C Janelsins, Matthew Asare, Po-Ju Lin and 5 more

2 registry-linked trialsAbstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 172 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed, 15 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00924651 nacompletednot on this map

A Study of the Effects of Exercise on Cancer-Related Fatigue

TypeinterventionalSponsorGary MorrowRan2009 to 2016Enrolled693ConditionsFatigue, Unspecified Adult Solid Tumor, Protocol SpecificArmsexercise
NCT04920097 nacompletednot on this mapstarted 2021, after this paper: background citation

Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy

TypeinterventionalSponsorThe University of Texas Health Science Center, HoustonRan2021 to 2026Enrolled238ConditionsChemotherapy-induced NeuropathyArmsIn-person training for seed placement and APA, Virtual training for seed placement and APA, Usual Care, Post-training zoom session for seed placement and APA coaching
3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 15 syntheses or guidelines pooled it, 303 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. The effects of exercise on chemotherapy-induced peripheral neuropathy symptoms in cancer patients: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Pooled it
  15. Pooled it
  16. Trial
  17. Trial
  18. Trial
  19. Supportive care: Comparing exercise interventions for upper extremity polyneuropathy induced by chemo- or immunotherapy - VISCIPH B.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Trial
  20. Trial

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Ian R KlecknerJames P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA. Ian_Kleckner@URMC.Rochester.edu.
Charles KamenJames P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Jennifer S GewandterJames P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Nimish A MohileJames P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Charles E HecklerJames P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Eva CulakovaJames P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Chunkit FungJames P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Michelle C JanelsinsJames P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Matthew AsareJames P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Po-Ju LinJames P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Pavan S ReddyWichita NCI Community Oncology Research Program (NCORP), Wichita, KS, USA.
Jeffrey GiguereGreenville NCORP, Greenville, SC, USA.
Jeffrey BerenbergHawaii NCORP, Honolulu, HI, USA.
Shelli R KeslerMD Anderson Cancer Center, Houston, TX, USA.
Karen M MustianJames P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
University of Rochester Medical Center · USGreenville College · USThe University of Texas MD Anderson Cancer Center · USUniversity of Hawaii System · US

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
UNIVERSITY OF ROCHESTER--CCOP RESEARCH BASEU10CA037420 · NCI · UNIVERSITY OF ROCHESTER · PI MORROW, GARY R · 1985 to 2014
$21.1M
The Hawaii NCORPUG1CA189804 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Jared Acoba, Jeffrey Lee Berenberg · 2014 to 2026
$15.7M
Cancer Control Research Training Curriculum (R25T)R25CA102618 · NCI · UNIVERSITY OF ROCHESTER · PI JANELSINS, MICHELLE C, MORROW, GARY R · 2004 to 2018
$6.7M
Exercise Intervention for Lesbian, Gay, Bisexual, and Transgender Cancer SurvivorsK07CA190529 · NCI · UNIVERSITY OF ROCHESTER · PI KAMEN, CHARLES STEWART · 2015 to 2019
$830k
Interventions Targeting Inflammation for Chemotherapy-Related Cognitive ProblemsK07CA168886 · NCI · UNIVERSITY OF ROCHESTER · PI JANELSINS, MICHELLE C · 2013 to 2017
$724k
National Cancer Institute R25 CA102618National Cancer Institute U10 CA037420NCI NIH HHS K07 CA168886NCI NIH HHS K07 CA190529NCI NIH HHS R25 CA102618NCI NIH HHS U10 CA037420NCI NIH HHS UG1 CA189804NCI NIH HHS UG1 CA189961
6 · The paper itself

Abstract

purposeOver half of all cancer patients receiving taxane-, platinum-, or vinca alkaloid-based chemotherapy experience chemotherapy-induced peripheral neuropathy (CIPN), which includes numbness, tingling, pain, cold sensitivity, and motor impairment in the hands and feet. CIPN is a dose-limiting toxicity, potentially increasing mortality. There are no FDA-approved drugs to treat CIPN, and behavioral interventions such as exercise are promising yet understudied. This secondary analysis of our nationwide phase III randomized controlled trial of exercise for fatigue examines (1) effects of exercise on CIPN symptoms, (2) factors that predict CIPN symptoms, and (3) factors that moderate effects of exercise on CIPN symptoms.

methodsCancer patients (N = 355, 56 ± 11 years, 93% female, 79% breast cancer) receiving taxane-, platinum-, or vinca alkaloid-based chemotherapy were randomized to chemotherapy or chemotherapy plus Exercise for Cancer Patients (EXCAP©®). EXCAP is a standardized, individualized, moderate-intensity, home-based, six-week progressive walking and resistance exercise program. Patients reported CIPN symptoms of numbness and tingling and hot/coldness in hands/feet (0-10 scales) pre- and post-intervention. We explored baseline neuropathy, sex, age, body mass index, cancer stage, and cancer type as possible factors associated with CIPN symptoms and exercise effectiveness.

resultsExercise reduced CIPN symptoms of hot/coldness in hands/feet (-0.46 units, p = 0.045) and numbness and tingling (- 0.42 units, p = 0.061) compared to the control. Exercise reduced CIPN symptoms more for patients who were older (p = 0.086), male (p = 0.028), or had breast cancer (p = 0.076).

conclusionsExercise appears to reduce CIPN symptoms in patients receiving taxane-, platinum-, or vinca alkaloid-based chemotherapy. Clinicians should consider prescribing exercise for these patients.

trial registrationClinical Trials.gov , # NCT00924651, http://www.clinicaltrials.gov .

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsBridged-Ring CompoundsExercise TherapyFemaleHumansMaleMiddle AgedNeoplasmsNeoplasm StagingOrganoplatinum CompoundsPeripheral Nervous System DiseasesTaxoidsVinca AlkaloidsBridged-Ring CompoundsOrganoplatinum CompoundstaxaneTaxoidsVinca AlkaloidsCIPNExerciseNeuropathy

Identifiers

PMID29243164
PMCPMC5823751
OpenAlexW2774164535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.